Imipramine-induced jitteriness and decreased serum iron levels.

Abstract	Jitteriness appears to be a specific side effect of tricyclic antidepressant treatment in panic disorder patients. In addition, the patients with jitteriness have lower serum iron levels compared to those that do not develop jitteriness (p = 0.01).
Authors	V K Yeragani, R Pohl, R Balon, C Ramesh, P Weinberg
Journal	Neuropsychobiology (Neuropsychobiology) Vol. 25 Issue 1 Pg. 8-10 ( 1992) ISSN: 0302-282X [Print] Switzerland
PMID	1603294 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
Chemical References	Antidepressive Agents Iron Imipramine
Topics	Adult Akathisia, Drug-Induced Antidepressive Agents (administration & dosage, adverse effects, therapeutic use) Double-Blind Method Female Humans Imipramine (adverse effects, therapeutic use) Iron (blood, metabolism) Male Panic Disorder (diagnosis, drug therapy, etiology) Prospective Studies Psychiatric Status Rating Scales Psychomotor Agitation (complications, psychology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!